Kimelman & Baird, LLC Organon & Co. Transaction History
Kimelman & Baird, LLC
- $1.21 Trillion
- Q2 2024
Shares
2 transactions
Others Institutions Holding OGN
# of Institutions
795Shares Held
191MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$651 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$603 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$202 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$180 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$148 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $5.08B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...